文献速递乳腺MR乳腺X线

高危女性全视野数字乳腺X线摄影阴性后与数字乳腺断层合成阴性后筛查乳腺MRI的表现比较

Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2018-12-12

回顾性比较2291例FFDM阴性后与2127例DBT阴性后筛查乳腺MRI:两组MRI补充癌症检出率无显著差异(11 vs 16/1000,OR 1.4,95%CI 0.4-1.2,P=0.23),异常解读率及PPV1-3亦无统计学差异,检出癌多为浸润性、小于1cm且淋巴结阴性。

要点

  • DBT阴性后MRI补充癌症检出率与FFDM阴性后相似,无显著差异。
  • 两组异常解读率约7.3%-7.4%,PPV1-3无统计学差异。
  • 检出癌多数为浸润性、小于1cm、淋巴结阴性。

核心结论

  • 在高于平均风险的女性中,DBT筛查阴性后MRI的补充癌症检出率与FFDM筛查阴性后MRI相似,多数检出癌为浸润性、亚厘米且淋巴结阴性。

研究设计与样本

  • 回顾性研究纳入4418次筛查乳腺MRI:FFDM组2291次于2010年1月至2012年1月期间在MRI前12个月内FFDM阴性者,DBT组2127次于2013年1月至2015年1月期间在MRI前12个月内DBT阴性者;筛查指征包括遗传易感、乳腺癌或高危病变个人史、胸部放疗史、家族史或其他使终生风险大于20%的危险因素。

诊断标准与关键数值

  • FFDM组MRI补充癌症检出率11/1000次检查 vs DBT组16/1000次检查,OR 1.4(95%CI 0.4-1.2),P=0.23;FFDM组AIR 7.4%、PPV1 15%、PPV2 23%、PPV3 28%,DBT组AIR 7.3%、PPV1 22%、PPV2 33%、PPV3 35%,均无统计学差异。

临床应用与阅片要点

  • 作者结论认为DBT筛查阴性后MRI补充癌症检出率与FFDM后相似,多数检出癌为浸润性、亚厘米且淋巴结阴性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to compare the supplemental cancer yield and performance of breast MRI in women at higher-than-average risk for breast cancer after negative 2D full-field digital mammography (FFDM) or negative digital breast tomosynthesis (DBT).

MATERIALS AND METHODS: Retrospective review identified 4418 screening breast MRI examinations: 2291 were performed from January 2010 through January 2012 of patients with a negative FFDM examination in the 12 months before MRI (FFDM group), and 2127 were performed from January 2013 through January 2015 of patients with a negative DBT examination in the 12 months before MRI (DBT group). Screening indications included genetic predisposition, personal history of breast cancer or high-risk lesion, prior chest irradiation, family history, or other risk factors conferring a lifetime risk of greater than 20%. Supplemental cancer detection rate (CDR), abnormal interpretation rate (AIR), and positive predictive values (PPVs) were estimated with 95% exact CIs. Logistic regression analysis, adjusting for differences in patient demographics, was used to compare metrics.

RESULTS: There was no significant difference in the CDR of MRI in the FFDM group versus the DBT group (11 vs 16 cancers per 1000 examinations, respectively; odds ratio, 1.4; 95% CI, 0.4-1.2; p = 0.23). The AIR, PPV1, PPV2, and PPV3 were 7.4%, 15%, 23%, and 28% for the FFDM group and 7.3%, 22%, 33%, and 35% for the DBT group, with no statistical differences. Of the cancers detected in both groups, the majority were invasive, less than 1 cm, and node-negative.

CONCLUSION: In women at higher-than-average risk of breast cancer screened with DBT, the supplemental CDR of MRI is similar to that of MRI after FFDM screening, with most cancers being invasive, subcentimeter, and node-negative.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Roark AA, Dang PA, Niell BL, et al. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer. AJR Am J Roentgenol. 2018. PMID: 30540208. doi:10.2214/AJR.18.19916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。